The prevalence and preventability of potentially relevant drug-drug interactions in patients admitted for cardiovascular diseases: A cross-sectional study.
Milena KovačevićSandra Vezmar KovačevićBranislava MiljkovićSlavica RadovanovićPredrag StevanovićPublished in: International journal of clinical practice (2017)
Use of drug interaction screening tools can be beneficial risk mitigation strategy for potentially relevant pDDIs in CVD patients. DDI screening software could be linked to the patient's laboratory results or clinical data regarding renal or liver function, as an approach to reinforce DDIs alert quality.
Keyphrases
- cardiovascular disease
- end stage renal disease
- adverse drug
- risk factors
- newly diagnosed
- ejection fraction
- peritoneal dialysis
- physical activity
- electronic health record
- prognostic factors
- big data
- emergency department
- type diabetes
- coronary artery disease
- patient reported outcomes
- cardiovascular risk factors
- artificial intelligence